GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Natco Pharma Ltd

Natco Pharma declares Rs. 1.25 interim dividend for FY27

DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 13 Nov 2026, 02:21 PM IST  ·  BSE ID: bb5284b0-e124-4be3-9b52-fa38c3e3dd02
View Original BSE Filing (PDF)
💡
In Simple Terms
The company is giving shareholders a special payment, called a dividend, of Rs. 1.25 for each share they own.
🤖 AI Summary
  • Natco Pharma Board declared Rs. 1.25 per share as 2nd interim dividend for FY27.
  • Dividend payout of Rs. 1.25 (62.50%) per equity share of Rs. 2 face value.
  • Record date for dividend eligibility is November 19, 2026.
  • Dividend payments are scheduled to begin from November 27, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Second Interim Dividend per Equity Share
Rs. 1.25 ps.
Percentage Dividend
62.50 %
Face Value per Equity Share
Rs. 2/-
Record Date
Thursday, 19th day of November, 2026
Payment Start Date
27th November, 2026
🏢 How This Affects the Company
💰
Financial Impact
The dividend distribution will reduce the company's cash reserves by the total payout amount.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time.
👤
Who Is Affected
Shareholders on record as of November 19, 2026, are eligible for the dividend payment.
🔍
Management Signal
The decision reflects management's intent to distribute profits to shareholders.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Dividend payment confirmation from the company.
Next Board meeting for Q3 FY27 results.
Annual report for FY2026-27.
LOW RISK Dividend declaration is a standard corporate action with no inherent company risk.
💡 Investor Takeaway
Natco Pharma declared a Rs. 1.25 per share (62.50%) second interim dividend for FY27, with a record date of November 19, 2026.
❓ Frequently Asked Questions
What is Natco Pharma's second interim dividend for FY27?
Natco Pharma declared a second interim dividend of Rs. 1.25 per equity share for FY27.
What is the dividend percentage declared by Natco Pharma for FY27?
The dividend of Rs. 1.25 per share on a face value of Rs. 2 represents 62.50%.
When is the record date for Natco Pharma's interim dividend?
The record date for determining eligible shareholders for the second interim dividend is November 19, 2026.
When will Natco Pharma start paying the interim dividend?
The payment of the declared second interim dividend will commence from November 27, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.